Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2012) 29 P868

ICEECE2012 Poster Presentations Endocrine tumours and neoplasia (112 abstracts)

Medullary thyroid carcinoma with liver metastasis presenting as watery diarrhea for 1 year

I. Lam 1 , H. Chaing 1 , C. Wang 2 & C. Chang 2


1Far-Eastern Memorial Hospital, New Taipei City, Taiwan; 2National Taiwan University Hospital, Taipei, Taiwan.


A 66-year-old woman had no history of systemic diseases. She had developed watery diarrhea for 4 months initially, without abdominal pain, fever, any aggravating or relieving factor. She visited gastroenterologist, and colonoscopy showed only mixed hemorrhoid. Irritable bowel syndrome was impressed then. Thus, anti-spasmodics and anti-diarrheals were prescribed. However, diarrhea persisted for 1 year, and body weight loss of 7 kg occurred during this period of time. She later visited a general practitioner, and abdominal ultrasonography revealed a 6.9 cm non-cirrhotic hepatic tumor. Her virological markers of HBsAg and anti-HCV were negative, and the serum alpha-fetoprotein level was within normal limits. She was referred to our hospital for further investigation. Tumor markers revealed high CEA (208.5 ng/ml) and normal CA19-9 (35.6 U/ml) levels. Tri-phase abdominal CT scan displayed three non-cirrhotic hypervascular lesions. After admission, core-needle biopsy for the largest hepatic tumor was arranged. Pathology revealed metastatic carcinoma, and immunohistochemical stains showed positive TTF-1, Calcitonin, and Synaptophysin. Thyroid ultrasonogrphy and fine needle aspiration were carried out, by which medullary thyroid carcinoma was impressed. Her serum calcitonin level was more than 10 000 pg/ml. Radical thyroidectomy and liver bi-segmentectomy were done. Amyloid accumulation was noted in the pathological specimens of thyroid and liver. The post-operative serum calcitonin level decreased to 3736 pg/ml, and diarrhea partially improved. Adjuvant chemotherapy was not suggested owing to futile outcome, and further target therapy is under evaluation.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

/media/12562/414004g1.gif

Volume 29

15th International & 14th European Congress of Endocrinology

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.